March 14, 2022

Chinese researchers find covid attacks human T-cells just like HIV does; not via usual ACE2 receptor

Paper just released claims to have discovered that in addition to attacking cells in the human airway that have "ACE2 receptors," covid also attacks human "killer T-cells"--the cells targeted by the HIV virus.  

The paper also claims to have found a specialized protein-- "gp120"--in the genome of covid, that is NOT present in the genome of any bat coronavirus.  The chances of this genome appearing in covid randomly are trillions to one against.

This article was not written by a bunch of random scientists, but instead was written by people from the Wuhan Institute of Virology, including the infamous batwoman Shi Zheng-Li. Just keep this in mind. It was originally submitted in Sep 2021 and revised in January 2022.

The researchers claim to have found the following:

    Many patients who had severe Sars-Cov-2 had depletion of the all important immune T-lymphocyte cells

    In experiments in which human T cells were infected with covid, the virus was able to infect the cells

    Covid normally infects airway cells that have ACE2 and TMPRSS2 receptors, but T cells do not have those receptors.

    Infection of T cells occurs via “LFA-1, the protein [that] exclusively expresses in multiple leukocytes”

    It turns out that HIV’s gp120 protein is the one that “Activates LFA-1 on CD4 T-Lymphocytes and Increases Cell Susceptibility to LFA-1-Targeting Leukotoxin”

    Earlier workers found that HIV’s gp120 protein is not in any bat coronavirus, and appears to have been inserted into Sars-Cov-2

    The gp120 protein is located in the spike protein of Sars-Cov-2, and this spike protein is used in all covid "vaccines”.

So, now we have a full new mystery: Sars-Cov-2 destroys immune T cells just like HIV does, Sars-Cov-2 has a transplanted gp120 HIV insert, and that specific gp120 insert is what enables HIV to enter lymphocytes via the LFA-1 receptor used by HIV.

Hmmmm....

Source 

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home